Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune checkpoints in the tumor microenvironment
Salman M. Toor, Varun Sasidharan Nair, Julie Decock, et al.
Seminars in Cancer Biology (2019) Vol. 65, pp. 1-12
Closed Access | Times Cited: 196

Showing 1-25 of 196 citing articles:

Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4
Shuang Qin, Linping Xu, Ming Yi, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 961
The updated landscape of tumor microenvironment and drug repurposing
Ming-Zhu Jin, Weilin Jin
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 893
Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways
Lukas Kraehenbuehl, Chien‐Huan Weng, Shabnam Eghbali, et al.
Nature Reviews Clinical Oncology (2021) Vol. 19, Iss. 1, pp. 37-50
Closed Access | Times Cited: 588
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
Adel Naimi, Rebar N. Mohammed, Ahmed Raji, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 283
Tumor microenvironment: barrier or opportunity towards effective cancer therapy
Aadhya Tiwari, Rakesh Trivedi, Shiaw‐Yih Lin
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 210
Resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms, predictive factors, and future perspectives
Jin‐Yu Sun, Dengke Zhang, Songquan Wu, et al.
Biomarker Research (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 182
Combination therapy with immune checkpoint inhibitors (ICIs); a new frontier
Somayeh Vafaei, Angelina Olegovna Zekiy, Ramadhan Ado Khanamir, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 170
CAR-macrophage: A new immunotherapy candidate against solid tumors
Yizhao Chen, Zhiying Yu, Xuewen Tan, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 139, pp. 111605-111605
Open Access | Times Cited: 164
Tumor microenvironment and immunotherapy of oral cancer
Chang Liu, Min Wang, Haiyang Zhang, et al.
European journal of medical research (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 77
Tumor microenvironment-responsive manganese-based nanomaterials for cancer treatment
Huanhuan Fan, Zijian Guo
Coordination Chemistry Reviews (2023) Vol. 480, pp. 215027-215027
Closed Access | Times Cited: 55
The CAR macrophage cells, a novel generation of chimeric antigen-based approach against solid tumors
Kaveh Hadiloo, Siavash Taremi, Mahmood Heidari, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 45
The tumor microenvironment: a key player in multidrug resistance in cancer
Lingnan Meng, Ying Zheng, Hao Liu, et al.
ONCOLOGIE (2024) Vol. 26, Iss. 1, pp. 41-58
Open Access | Times Cited: 18
Immunotherapy in melanoma: Can we predict response to treatment with circulating biomarkers?
Elena Splendiani, Zein Mersini Besharat, Alessia Covre, et al.
Pharmacology & Therapeutics (2024) Vol. 256, pp. 108613-108613
Open Access | Times Cited: 17
Understanding Cancer’s Defense against Topoisomerase-Active Drugs: A Comprehensive Review
Nilesh Kumar Sharma, Anjali Bahot, Gopinath Sekar, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 680-680
Open Access | Times Cited: 16
Immune Checkpoints in Circulating and Tumor-Infiltrating CD4+ T Cell Subsets in Colorectal Cancer Patients
Salman M. Toor, Khaled Murshed, Mahmood Al‐Dhaheri, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 126
Breast Cancer Cells and PD-1/PD-L1 Blockade Upregulate the Expression of PD-1, CTLA-4, TIM-3 and LAG-3 Immune Checkpoints in CD4+ T Cells
Reem Saleh, Salman M. Toor, Sarah Khalaf, et al.
Vaccines (2019) Vol. 7, Iss. 4, pp. 149-149
Open Access | Times Cited: 95
Metal–organic frameworks (MOFs) as host materials for the enhanced delivery of biomacromolecular therapeutics
Peihong Tong, Ling Zhu, Yi Zang, et al.
Chemical Communications (2021) Vol. 57, Iss. 91, pp. 12098-12110
Open Access | Times Cited: 84
Role of Epigenetic Modifications in Inhibitory Immune Checkpoints in Cancer Development and Progression
Reem Saleh, Salman M. Toor, Varun Sasidharan Nair, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 80
Long Non-coding RNAs: Emerging Roles in the Immunosuppressive Tumor Microenvironment
Ya Luo, Jiqiao Yang, Jing Yu, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 72
Immune Checkpoint Inhibitor‐Based Strategies for Synergistic Cancer Therapy
Mengying He, Tao Yang, Yuhan Wang, et al.
Advanced Healthcare Materials (2021) Vol. 10, Iss. 9
Closed Access | Times Cited: 63
Bacterial outer membrane vesicles-based therapeutic platform eradicates triple-negative breast tumor by combinational photodynamic/chemo-/immunotherapy
Yongjiang Li, Junyong Wu, Xiaohan Qiu, et al.
Bioactive Materials (2022) Vol. 20, pp. 548-560
Open Access | Times Cited: 63
Role of CD68 in tumor immunity and prognosis prediction in pan-cancer
Jingwei Zhang, Shuwang Li, Fangkun Liu, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 55
Enhancing the Efficiency of Mild-Temperature Photothermal Therapy for Cancer Assisting with Various Strategies
Pei Wang, Biao‐Qi Chen, Yunyan Zhan, et al.
Pharmaceutics (2022) Vol. 14, Iss. 11, pp. 2279-2279
Open Access | Times Cited: 44
Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma
Shailendra K. Gautam, Surinder K. Batra, Maneesh Jain
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 39
The application of HER2 and CD47 CAR-macrophage in ovarian cancer
Yizhao Chen, Xiangling Zhu, Hanze Liu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 39
Page 1 - Next Page

Scroll to top